Gene · 5997
Papers1,532
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,532
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prediction of prostate cancer biochemical recurrence by using discretization supports the critical contribution of the extra-cellular matrix genes. | Sci Rep | 2023 | 37349324 | PubTator, text mining | PubMed |
| Neurostimulation as a Putative Method for the Treatment of Drug-resistant Epilepsy in Patient and Animal Models of Epilepsy. | Basic Clin Neurosci | 2023 | 37346878 | PubTator, text mining | PubMed |
| A novel smart multilevel security approach for secure data outsourcing in crisis. | PeerJ Comput Sci | 2023 | 37346672 | PubTator, text mining | PubMed |
| Moderate intrinsic phenotypic alterations in C9orf72 ALS/FTD iPSC-microglia despite the presence of C9orf72 pathological features. | Front Cell Neurosci | 2023 | 37346371 | PubTator, text mining | PubMed |
| iPSC-based approach for human hair follicle regeneration. | Front Cell Dev Biol | 2023 | 37325563 | PubTator, text mining | PubMed |
| Probiotics and Commensal Bacteria Metabolites Trigger Epigenetic Changes in the Gut and Influence Beneficial Mood Dispositions. | Microorganisms | 2023 | 37317308 | PubTator, text mining | PubMed |
| Preconditioned Chorionic Villus Mesenchymal Stem/Stromal Cells (CVMSCs) Minimize the Invasive Phenotypes of Breast Cancer Cell Line MDA231 In Vitro. | Int J Mol Sci | 2023 | 37298519 | PubTator, text mining | PubMed |
| Extracellular vesicles from human plasma dampen inflammation and promote tissue repair functions in macrophages. | J Extracell Vesicles | 2023 | 37272889 | PubTator, text mining | PubMed |
| Editorial: Oxytocin in brain health and disease: how can it exert such pleiotropic neuromodulatory effects? | Front Mol Neurosci | 2023 | 37266372 | PubTator, text mining | PubMed |
| Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq. | Front Immunol | 2023 | 37256127 | PubTator, text mining | PubMed |
| NatB Catalytic Subunit Depletion Disrupts DNA Replication Initiation Leading to Senescence in MEFs. | Int J Mol Sci | 2023 | 37240070 | PubTator, text mining | PubMed |
| A T-cell-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma based on transcriptomics and single-cell sequencing. | BMC Bioinformatics | 2023 | 37231356 | PubTator, text mining | PubMed |
| The third intracellular loop of GPCRs: size matters. | Trends Pharmacol Sci | 2023 | 37208206 | PubTator, text mining | PubMed |
| The metastatic niche formation: focus on extracellular vesicle-mediated dialogue between lung cancer cells and the microenvironment. | Front Oncol | 2023 | 37207158 | PubTator, text mining | PubMed |
| RGS2-mediated translational control mediates cancer cell dormancy and tumor relapse. | J Clin Invest | 2023 | 37183821 | PubTator, text mining | PubMed |
| New insights into irritable bowel syndrome pathophysiological mechanisms: contribution of epigenetics. | J Gastroenterol | 2023 | 37160449 | PubTator, text mining | PubMed |
| Common mechanisms of physiological and pathological rupture events in biology: novel insights into mammalian ovulation and beyond. | Biol Rev Camb Philos Soc | 2023 | 37157877 | PubTator, text mining | PubMed |
| Triple immune modulator therapy for aberrant hyperinflammatory responses in severe COVID-19. | Clin Immunol | 2023 | 37119951 | PubTator, text mining | PubMed |
| RGS proteins and their roles in cancer: friend or foe? | Cancer Cell Int | 2023 | 37118788 | PubTator, text mining | PubMed |
| Oxidants and Cardiorenal Vascular Remodeling-Insights from Rare Genetic Tubulopathies: Bartter's and Gitelman's Syndromes. | Antioxidants (Basel) | 2023 | 37107186 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5997/papers?page=8